Nature Reviews Drug Discovery 13, 491–492 (2014)
In the text of the article, cobimetinib was incorrectly described as a BRAF inhibitor, but is actually a MEK inhibitor. The online version of the article has been corrected accordingly.
Additional information
The online version of the original article can be found at 10.1038/nrd4326
Rights and permissions
About this article
Cite this article
Webster, R., Mentzer, S. Erratum: The malignant melanoma landscape. Nat Rev Drug Discov 13, 638 (2014). https://doi.org/10.1038/nrd4401
Published:
Issue date:
DOI: https://doi.org/10.1038/nrd4401
